- Home
- APGE vs RGTI Comparison
APGE vs RGTI Comparison
Compare APGE & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | RGTI |
|---|---|---|
| Founded | 2022 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.7B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APGE | RGTI |
|---|---|---|
| Price | $134.97 | $15.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $109.67 | $30.78 |
| AVG Volume (30 Days) | 1.2M | ★ 17.8M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,102,000.00 |
| Revenue This Year | N/A | $225.06 |
| Revenue Next Year | N/A | $99.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.86 |
| 52 Week Low | $35.39 | $12.53 |
| 52 Week High | $134.99 | $58.15 |
Technical Indicators
Market Signals| Indicator | APGE | RGTI |
|---|---|---|
| Relative Strength Index (RSI) | 77.86 | 44.02 |
| Support Level | $134.03 | $15.30 |
| Resistance Level | N/A | $16.30 |
| Average True Range (ATR) | 0.13 | 1.01 |
| MACD | -0.49 | -0.19 |
| Stochastic Oscillator | 93.56 | 0.94 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.